Cambridge Investment Research Advisors, Inc. Illumina, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Illumina, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 3,697 shares of ILMN stock, worth $518,097. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,697
Previous 5,297 30.21%
Holding current value
$518,097
Previous $553,000 12.84%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$105.28 - $135.9 $168,448 - $217,440
-1,600 Reduced 30.21%
3,697 $482,000
Q2 2024

Jul 26, 2024
SELL
$101.05 - $133.57 $1.01 Million - $1.34 Million
-10,031 Reduced 65.44%
5,297 $553,000
Q1 2024

Apr 24, 2024
SELL
$127.73 - $147.2 $253,927 - $292,633
-1,988 Reduced 11.48%
15,328 $2.11 Million
Q4 2023

Feb 09, 2024
BUY
$92.79 - $142.53 $920,291 - $1.41 Million
9,918 Added 134.06%
17,316 $2.41 Million
Q3 2023

Oct 24, 2023
BUY
$128.91 - $192.44 $291,078 - $434,529
2,258 Added 43.93%
7,398 $1.02 Million
Q2 2023

Jul 13, 2023
BUY
$183.43 - $232.67 $169,305 - $214,754
923 Added 21.89%
5,140 $964,000
Q1 2023

May 11, 2023
SELL
$193.75 - $232.55 $388,662 - $466,495
-2,006 Reduced 32.24%
4,217 $981,000
Q4 2022

Feb 08, 2023
SELL
$187.24 - $242.74 $541,872 - $702,489
-2,894 Reduced 31.74%
6,223 $1.26 Million
Q3 2022

Oct 17, 2022
SELL
$177.23 - $227.44 $69,296 - $88,929
-391 Reduced 4.11%
9,117 $1.74 Million
Q2 2022

Jul 13, 2022
BUY
$181.58 - $368.0 $279,451 - $566,352
1,539 Added 19.31%
9,508 $1.75 Million
Q1 2022

May 12, 2022
SELL
$303.87 - $423.8 $807,990 - $1.13 Million
-2,659 Reduced 25.02%
7,969 $2.78 Million
Q4 2021

Feb 03, 2022
BUY
$347.28 - $421.83 $1.04 Million - $1.27 Million
3,009 Added 39.49%
10,628 $4.04 Million
Q3 2021

Nov 02, 2021
SELL
$405.61 - $524.84 $142,369 - $184,218
-351 Reduced 4.4%
7,619 $3.09 Million
Q2 2021

Aug 10, 2021
BUY
$372.84 - $481.5 $247,192 - $319,234
663 Added 9.07%
7,970 $3.77 Million
Q1 2021

May 07, 2021
SELL
$361.28 - $504.76 $469,302 - $655,683
-1,299 Reduced 15.09%
7,307 $2.81 Million
Q4 2020

Feb 04, 2021
BUY
$292.7 - $370.96 $959,763 - $1.22 Million
3,279 Added 61.55%
8,606 $3.18 Million
Q3 2020

Oct 29, 2020
SELL
$268.51 - $400.74 $229,844 - $343,033
-856 Reduced 13.84%
5,327 $1.65 Million
Q2 2020

Jul 27, 2020
SELL
$256.46 - $373.01 $242,098 - $352,121
-944 Reduced 13.25%
6,183 $2.29 Million
Q1 2020

May 08, 2020
BUY
$209.2 - $335.53 $109,620 - $175,817
524 Added 7.94%
7,127 $1.95 Million
Q4 2019

Feb 04, 2020
BUY
$288.29 - $335.49 $38,054 - $44,284
132 Added 2.04%
6,603 $2.19 Million
Q3 2019

Nov 06, 2019
SELL
$266.84 - $378.23 $545,420 - $773,102
-2,044 Reduced 24.0%
6,471 $1.97 Million
Q3 2019

Oct 28, 2019
BUY
$266.84 - $378.23 $409,599 - $580,583
1,535 Added 21.99%
8,515 $2.59 Million
Q2 2019

Aug 15, 2019
SELL
$300.59 - $368.15 $163,520 - $200,273
-544 Reduced 7.23%
6,980 $0
Q1 2019

May 08, 2019
BUY
$272.57 - $321.18 $119,658 - $140,998
439 Added 6.2%
7,524 $0
Q4 2018

Feb 05, 2019
BUY
$272.46 - $366.54 $205,434 - $276,371
754 Added 11.91%
7,085 $2.13 Million
Q3 2018

Nov 02, 2018
BUY
$279.04 - $367.06 $824,563 - $1.08 Million
2,955 Added 87.53%
6,331 $0
Q2 2018

Aug 10, 2018
SELL
$228.17 - $292.07 $341,570 - $437,228
-1,497 Reduced 30.72%
3,376 $0
Q1 2018

May 09, 2018
BUY
$209.54 - $253.91 $327,301 - $396,607
1,562 Added 47.18%
4,873 $0
Q4 2017

Feb 22, 2018
SELL
$202.23 - $230.03 $44,288 - $50,376
-219 Reduced 6.2%
3,311 $0
Q3 2017

Nov 07, 2017
SELL
$172.3 - $213.93 $1.19 Million - $1.48 Million
-6,917 Reduced 66.21%
3,530 $703,000
Q2 2017

Aug 08, 2017
BUY
N/A
10,447
10,447 $1.81 Million

Others Institutions Holding ILMN

# of Institutions
899
Shares Held
137M
Call Options Held
1.22M
Put Options Held
1.43M
View Full List

About ILLUMINA, INC.

ILMN Quotes by TradingView
  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email